António L. Grilo is a PhD Student interested in bioprocess development. At present, his research focuses on mathematical modelling of upstream mAb production. In the past, he was a researcher at the BioSeparations Laboratory at IST, (Lisbon, Portugal) and Amgen, Inc. (Seattle, WA, USA) working in Purification Process Development.
António obtained an MSc. and a BSc. in Biochemical Engineering from Instituto Superior Técnico (IST), University of Lisbon, Portugal in 2013 and 2011 respectively. He was also a Petroelum Engineering trainee at Galp Energia and obtained an MSc. in Petroleum Engineering from Heriot-Watt University in 2015. He joined Imperial College in 2016.
Grilo AL, Mantalaris A, 2019, Apoptosis: A mammalian cell bioprocessing perspective, Biotechnology Advances, ISSN:0734-9750
Martins De Jesus Lima Grilo A, Mantalaris A, 2018, The increasingly human and profitable monoclonal antibody market, Trends in Biotechnology, ISSN:0167-7799
et al., 2017, Monoclonal Antibodies Production Platforms: An Opportunity Study of a Non-Protein-A Chromatographic Platform Based on Process Economics., Biotechnol J
Grilo A, Quiroga-Campano A, Mantalaris A, A predictive model of cell-cycle, metabolism and apoptosis of mAb-producing GS-NS0 cells., Cell Culture Engineering
et al., Model-based process development, Commercializing Continuous Manufacturing in Pharma